Correction to: Development and Utility of an ELISA Method for Sensitive and Specific Detection of IgE Antidrug Antibodies

Lynn L Jiang; Puneet Khandelwal; Adam W Clarke; Ray Bakhtiar; Linglong Zou; Zhandong Don Zhong

doi:10.1208/s12248-020-00439-y

Correction to: Development and Utility of an ELISA Method for Sensitive and Specific Detection of IgE Antidrug Antibodies

AAPS J. 2020 Mar 16;22(3):57. doi: 10.1208/s12248-020-00439-y.

Authors

Lynn L Jiang¹, Puneet Khandelwal¹, Adam W Clarke², Ray Bakhtiar¹, Linglong Zou³, Zhandong Don Zhong⁴

Affiliations

¹ Specialty Bioanalytics, Teva Pharmaceuticals Inc., West Chester, Pennsylvania, 19380, USA.
² R&D, Biologics, Lead Antibody Discovery, Teva Pharmaceuticals, Sydney, NSW, Australia.
³ Biologics Assays & Technology, Teva Pharmaceuticals Inc., West Chester, Pennsylvania, 19380, USA.
⁴ Specialty Bioanalytics, Teva Pharmaceuticals Inc., West Chester, Pennsylvania, 19380, USA. don.zhong@tevapharm.com.

PMID: 32185532
DOI: 10.1208/s12248-020-00439-y

Abstract

During the production process, the author order of Zhandong Don Zhong and Lynn L. Jiang were inadvertently placed. Lynn L. Jiang is the first author of this manuscript; Zhandong Don Zhong is the last author.

Publication types

Published Erratum